Investing.com – Israel equities were higher at the close on Thursday, as gains in the Biomed, Technology and Insurance sectors propelled shares higher.
At the close in Tel Aviv, the TA 35 gained 0.97%.
The biggest gainers of the session on the TA 35 were Teva Pharmaceutical Industries Ltd (TA:TEVA), which rose 7.50% or 504 points to trade at 7227 at the close. Israel Corp (TA:ILCO) added 7.00% or 4320 points to end at 66000 and Mylan NV (TA:MYL) was up 3.87% or 580 points to 15580 in late trade.
Biggest losers included Azrieli Group Ltd (TA:AZRG), which lost 1.52% or 290 points to trade at 18820 in late trade. Isramco Negev 2 LP (TA:ISRAp) declined 1.33% or 0.6 points to end at 44.4 and Bezeq Israeli Telecommunication Corp Ltd (TA:BEZQ) shed 1.30% or 6.8 points to 516.2.
Advancing stocks outnumbered falling ones by 256 to 136 and 30 ended unchanged on the Tel Aviv Stock Exchange.
In commodities trading, Crude oil for February delivery was up 1.37% or 0.87 to $64.44 a barrel. Meanwhile, Brent oil for delivery in March rose 0.84% or 0.58 to hit $69.78 a barrel, while the February Gold Futures contract rose 0.15% or 2.00 to trade at $1321.30 a troy ounce.
USD/ILS was down 0.19% to 3.4201, while EUR/ILS rose 0.60% to 4.1190.
The US Dollar Index Futures was down 0.53% at 91.62.